Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on stem cell biology and engineering for brain development.

C J C Parr1, S Yamanaka1,2, H Saito1

  • 1Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Molecular Psychiatry
|April 5, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased superoxide dismutase activity in erythrocyte in Parkinson's disease.

The Japanese journal of psychiatry and neurology·1992
Same author

[Application of ultrasonography in chest diseases--usefulness of ultrasonography and physiologic evaluation of low pressure vascular system].

Nihon Kyobu Shikkan Gakkai zasshi·1992
Same author

Recent advances in the study of hepatocellular carcinoma.

The Keio journal of medicine·1992
Same author

Evaluation of cor pulmonale on a modified short-axis section of the heart by magnetic resonance imaging.

The American review of respiratory disease·1992
Same author

Impaired secretion of the elongated mutant of protein C (protein C-Nagoya). Molecular and cellular basis for hereditary protein C deficiency.

The Journal of clinical investigation·1992
Same author

A 50-year-old man with ulcerative colitis and severe anemia.

The Keio journal of medicine·1992

Induced-pluripotent stem cells (iPSCs) and direct reprogramming offer promise for central nervous system (CNS) therapies. This review details current methods for generating human brain cells, highlighting variations in efficiency, purity, and maturation.

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Induced-pluripotent stem cells (iPSCs) and direct somatic reprogramming are key technologies for cell-based therapies.
  • Generating diverse human brain cell types is achievable using these methods.
  • Existing protocols for cell generation show significant variability in outcomes.

Purpose of the Study:

  • To provide an overview of current methods for generating human brain cells from iPSCs and via direct reprogramming.
  • To analyze the efficiencies, purity, and maturation levels of cells produced by different protocols.
  • To discuss potential solutions and future perspectives for CNS disease modeling and brain development research.

Main Methods:

  • Review of existing literature on iPSC differentiation and direct somatic reprogramming for neural cell generation.

Related Experiment Videos

  • Analysis of protocol variations impacting cell yield, purity, and developmental stage.
  • Exploration of enabling technologies like micro-RNA switches for cell purification.
  • Assessment of the shift from 2D cultures to 3D organoid (mini-brain) models.

    • Main Results:

    • Methods for generating major human brain cell types are established.
    • Significant variability exists in the efficiency, purity, and maturation of reprogrammed/differentiated cells.
    • Micro-RNA switch technologies show potential for enhancing target cell purification.
    • 3D organoid models represent an advancement over 2D cultures for studying brain development and disease.

    Conclusions:

    • iPSCs and direct reprogramming hold significant therapeutic potential for central nervous system disorders.
    • Standardization and optimization of protocols are crucial for clinical translation.
    • Advanced culture systems, including brain organoids, offer powerful tools for in vitro modeling of neurological conditions and development.